Pope Leo’s diagnosis of lung cancer last month has put the spotlight on the condition. The pontiff was found to have early stage adenocarcinoma of the lung following a routine check-up.

After removing the lower lobe of his right lung, his doctors announced the growth was localised and that he would need no further treatment.

But Pope Leo’s diagnosis has sparked discussion about increasing rates of lung cancer among people who have never smoked. Besides smoking and second-hand smoke, there are several other risk factors. These include a family history of cancer and exposure to asbestos, radon and air pollution. And in some parts of the world exposure to inhaled chemicals such as arsenic, beryllium, cadmium, silica and nickel remains a risk.

Lung cancer is the leading cause of cancer death globally, with 1.9 million deaths in 2024. It is also a leading cause of cancer-related mortality in Ireland, accounting for about 1,900 deaths annually. There are two broad groups of lung cancer: non-small-cell carcinoma and small-cell lung carcinoma. Each type behaves in different ways and requires different treatment. Most lung cancers are non-small-cell lung cancer of which adenocarcinoma is the most common type. It is found in the mucous glands in the outer region of the lungs.

Symptoms of lung cancer can include coughing, shortness of breath, fatigue and pain in the back, chest or shoulder. However, lung cancer is often diagnosed late, when treatment is more challenging and survival rates are lower. Five-year survival for lung cancer is 57 per cent for stage one compared with 4 per cent for stage four.

[ ‘Nothing else seemed wrong. I was normal but with a cough’ – Venetia Hill on her surprising cancer diagnosisOpens in new window ]

The most effective way of preventing lung cancer is primary prevention, mainly tobacco control. Screening for the disease has emerged as a complementary approach to reduce death by detecting the disease at an earlier, more treatable stage.

In its most recent review, the Handbooks of Cancer Prevention programme of the International Agency for Research on Cancer has evaluated the benefits and harms of lung cancer screening. The working group concluded that screening high-risk individuals, based on age and smoking history, with low-dose computed tomography reduced mortality and reduced the incidence of late-stage lung cancer.

But research published in the Journal of the American Medical Association found that while lung cancer screening has clear benefits, it can cause harm as well. More than 10 per cent of individuals who undergo lung cancer screening experience a false-positive result, and patients may experience complications such as pneumothorax and bleeding into a chest cavity during a biopsy procedure. False-positive results may further lead to anxiety and additional out-of-pocket costs. Screening can also lead to overdiagnosis – the identification and treatment of lung cancer that would not be associated with increased morbidity or mortality if left undetected.

Meanwhile, in 2022 lung cancer was included in the updated Council of the EU recommendations on cancer screening. Ireland does not yet have a national lung cancer screening programme, but it has launched a pilot study. Lung Health Check is run by Beaumont Hospital and the RCSI University of Medicine and Health Sciences, and is funded by the Irish Cancer Society and the EU4Health Solace programme.

[ Lung cancer pilot programme identifies some patients before symptoms appearOpens in new window ]

The pilot invites people at high risk (adults aged 55–74 with a smoking history) and identified through selected GP practices, to attend a mobile unit for a respiratory assessment and a low-dose CT scan. The mobile units are in community settings, most notably local GAA clubs, bringing screening closer to where people live, and reducing a key barrier to uptake.

The Irish pilot has already achieved participation rates exceeding 70 per cent.

Initial results of its effectiveness in reducing mortality from lung cancer are expected within months.

mhouston@irishtimes.com

Source: The Irish Times · Muiris Houston

At a glance

Topic
Health
Country
🇮🇪 IE
Publisher language
EN
Added to Allnira